PEGS Boston

Join Applied Photophysics at the PEGS Summit to learn about cutting-edge protein and antibody engineering solutions.  We are devoted to providing you with the resources and knowledge you need to succeed.

Visit us at the summit to learn more!

The 2025 PEGS Boston Summit, scheduled for May 12–16 at the Seaport World Trade Center in Boston, MA, is a premier global event for biologics and protein engineering. Organized by Cambridge Healthtech Institute, this 21st annual summit will bring together over 2,400 participants, including scientists, innovators, and industry leaders, to explore cutting-edge advancements in drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research.

The summit will include over 20 conference tracks and training workshops on themes like protein and antibody engineering, bispecific antibody development, AI/ML integration in biologics research, and radiopharmaceutical therapy. More than 350 presenters will provide unique lectures and case studies. Panel discussions and interactive breakout sessions will offer opportunity for small-group learning and collaboration. Attendees can learn about cutting-edge technologies and services tailored to speed biotherapeutics research from more than 120 exhibitors and numerous sponsored presentations. Including our Applied Photophysics team.

The PEGS Boston Summit remains a must-attend event for professionals looking to stay on the cutting edge of biologics innovation. It provides an unprecedented opportunity for learning, cooperation, and discovery in biotherapeutics research. So come see our exhibit at Booth 23 and hear about our efforts and what we've accomplished to date.

Sign up 

Ellen Puré, PhD, Chair & Professor, Biomedical Sciences, University of Pennsylvania
Ellen Puré, Ph.D., is the Grace Lansing Lambert Professor, former Chair of Biomedical Sciences, Professor of Systems Pharmacology and Translational Therapeutics, and founding Director of the Penn Vet Cancer Center at the University of Pennsylvania. Dr. Puré received her Baccalaureate degree from Washington University in St. Louis, and her doctorate from the University of Texas-Southwestern Medical School. She trained as a Damon Runyon-Walter Winchell Postdoctoral Fellow and Leukemia Society Special Fellow and then joined the Faculty at the Rockefeller University. In 1992, Dr. Puré moved to Philadelphia where she was on the Faculty of the Wistar Institute until moving to the University of Pennsylvania in 2013. Dr. Puré is an Associate Director of the Cancer Research Institute and currently serves as a consulting editor of the Journal of Clinical Investigation and is a Founding Senior Editor of Cancer Immunology Research. Dr. Puré’s research focuses on the cellular and molecular basis of fibroinflammation. She studies the basic mechanisms of fibroinflammation in the context of fibrotic diseases and cancer. Her laboratory has made seminal contributions to our understanding of the roles of stromal cells and extracellular matrix remodeling in tissue fibrosis and in cancer risk, initiation, progression, and metastasis. Her lab is developing novel therapeutic approaches to target stroma to treat fibrosis and cancer. In 2019, Dr. Puré was named a Fellow of the American Association for the Advancement of Science (AAAS). Dr. Puré is a scientific co-founder of Capstan Therapeutics.

Jessica C. Stark, PhD, Underwood-Prescott Career Development Professor, MIT
Jessica Stark is an Assistant Professor in the departments of Biological Engineering and Chemical Engineering at MIT and an intramural member of the Koch Institute for Integrative Cancer Research. The Stark Lab is developing biological technologies to realize the largely untapped potential of glycans for immunological discovery and immunotherapy. As an American Cancer Society Postdoctoral Fellow with Prof. Carolyn Bertozzi at Stanford University, Jessica’s work focused on identifying and targeting glycans that act as immune checkpoints for next-generation cancer immunotherapy. As an NSF Graduate Research Fellow with Prof. Michael Jewett at Northwestern University, Jessica developed cell-free technologies for protein therapeutic and vaccine production that promise to enable portable and personalized medicine. Previously, she received her B.S. in Chemical and Biomolecular Engineering from Cornell University and worked at Genentech, Inc. in process development and research and development roles. Jessica’s independent work has been recognized with a Burroughs Wellcome Fund Career Award at the Scientific Interface, the Society for Immunotherapy of Cancer’s Steven A. Rosenberg Scholar Award, and a V Foundation V Scholar Award. The Stark lab is committed to enhancing diversity, equity, and inclusion in STEM through mentoring, outreach, and service activities. To support this work, Jessica co-developed and commercialized BioBits educational kits that promise to increase access to high-quality biology education by facilitating hands-on learning.